Montgomery; Alan Bruce

Patent Applications and Registrations

Patent applications and USPTO patent grants for Montgomery; Alan Bruce.The latest application filed is for "inhalable aztreonam for treatment and prevention of pulmonary bacterial infections".

Company Profile

0.30.32

Montgomery; Alan Bruce - Medina WA
Montgomery; Alan Bruce - Seattle WA US
Montgomery; Alan Bruce - Bellevue WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 10,471,083 - Montgomery Nov	2019-11-12
Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties Grant 10,406,171 - Montgomery Sept	2019-09-10
Inhalable Aztreonam For Treatment And Prevention Of Pulmonary Bacterial Infections App 20170296517 - Montgomery; Alan Bruce	2017-10-19
Formulations Of Aminoglycosides And Fosfomycin In A Combination Having Improved Chemical Properties App 20170296562 - Montgomery; Alan Bruce	2017-10-19
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections Grant 9,533,000 - Montgomery January 3, 2	2017-01-03
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 9,526,697 - Montgomery December 27, 2	2016-12-27
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 9,526,696 - Montgomery December 27, 2	2016-12-27
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 9,526,695 - Montgomery December 27, 2	2016-12-27
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 9,526,698 - Montgomery December 27, 2	2016-12-27
Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties Grant 9,486,462 - Montgomery November 8, 2	2016-11-08
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20160143932 - Montgomery; Alan Bruce	2016-05-26
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20160143847 - Montgomery; Alan Bruce	2016-05-26
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20160143933 - Montgomery; Alan Bruce	2016-05-26
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20160143931 - Montgomery; Alan Bruce	2016-05-26
Formulations Of Aminoglycosides And Fosfomycin In A Combination Having Improved Chemical Properties App 20150057241 - Montgomery; Alan Bruce	2015-02-26
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20150057242 - MONTGOMERY; ALAN BRUCE	2015-02-26
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections Grant 8,841,286 - Montgomery September 23, 2	2014-09-23
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 8,826,904 - Montgomery September 9, 2	2014-09-09
Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 8,820,323 - Montgomery September 2, 2	2014-09-02
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20140221302 - Montgomery; Alan Bruce	2014-08-07
Inhalable Aztreonam For Treatment And Prevention Of Pulmonary Bacterial Infections App 20140037735 - Montgomery; Alan Bruce	2014-02-06
Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 8,636,983 - Montgomery January 28, 2	2014-01-28
Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 8,636,984 - Montgomery January 28, 2	2014-01-28
Methods to Administer Formulations of Aminoglycoside and Fosfomycin Combination for Treatment of Ventilator Associated Pneumonia (VAP) and Ventilator Associated Tracheal (VAT) Bronchitis App 20140014107 - Montgomery; Alan Bruce	2014-01-16
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis Grant 8,603,439 - Montgomery December 10, 2	2013-12-10
Aerosol Formulation of Aminoglycoside and Fosfomycin Combination for Treatment of Ventilator Associated Pneumonia (VAP) and Ventilator Associated Tracheal (VAT) Bronchitis App 20130302423 - Montgomery; Alan Bruce	2013-11-14
Aminoglycoside and Fosfomycin Combination for Treatment of Ventilator Associated Pneumonia (VAP) and Ventilator Associated Tracheal (VAT) Bronchitis App 20130303476 - Montgomery; Alan Bruce	2013-11-14
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20130263852 - Montgomery; Alan Bruce	2013-10-10
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections Grant 8,399,496 - Montgomery , et al. March 19, 2	2013-03-19
Formulations Of Aminoglycoside And Fosfomycin Combinations And Methods And Systems For Treatment Of Ventilator Associated Pneumonia (vap) And Ventilator Associated Tracheal (vat) Bronchitis App 20130014759 - Montgomery; Alan Bruce	2013-01-17
Inhalable Aztreonam Lysinate Formulation For Treatment And Prevention Of Pulmonary Bacterial Infections App 20120251585 - Montgomery; Alan Bruce	2012-10-04
Inhalable Aztreonam For Treatment And Prevention Of Pulmonary Bacterial Infections App 20120093890 - Montgomery; Alan Bruce	2012-04-19
Method for improvement of tolerance for therapeutically effective agents delivered by inhalation Grant 8,003,081 - Hofmann , et al. August 23, 2	2011-08-23
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacks Grant 7,998,463 - Hofmann , et al. August 16, 2	2011-08-16
Targeted Delivery of Lidocaine and Other Local Anesthetics and A Method For Treatment of Cough, Asthma and Tussive Attacks App 20090041676 - HOFMANN; THOMAS ; et al.	2009-02-12
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections App 20090028801 - Montgomery; Alan Bruce	2009-01-29
Method For Improvement Of Tolerance For Therapeutically Effective Agents Delivered By Inhalation App 20090004279 - Hofmann; Thomas ; et al.	2009-01-01
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks Grant 7,452,523 - Hofmann , et al. November 18, 2	2008-11-18
Method for improvement of tolerance for therapeutically effective agents delivered by inhalation Grant 7,452,524 - Hofmann , et al. November 18, 2	2008-11-18
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections Grant 7,427,633 - Montgomery September 23, 2	2008-09-23
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections App 20080050439 - Montgomery; Alan Bruce	2008-02-28
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial inections App 20070185076 - Montgomery; Alan Bruce	2007-08-09
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections Grant 7,214,364 - Montgomery May 8, 2	2007-05-08
Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections Grant 7,208,141 - Montgomery April 24, 2	2007-04-24
Process for manufacturing bulk solutions and a lyophilized pure .alpha.-aztreonam lysinate Grant 7,138,419 - Montgomery , et al. November 21, 2	2006-11-21
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks App 20060062737 - Hofmann; Thomas ; et al.	2006-03-23
Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients App 20060062739 - Hofmann; Thomas ; et al.	2006-03-23
Method for improvement of tolerance for therapeutically effective agents delivered by inhalation App 20060062738 - Hofmann; Thomas ; et al.	2006-03-23
Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections App 20050129623 - Montgomery, Alan Bruce	2005-06-16
Process for manufacturing bulk solutions and a lyophilized pure alpha-aztreonam lysinate App 20050063912 - Montgomery, Alan Bruce ; et al.	2005-03-24
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections App 20040062721 - Montgomery, Alan Bruce	2004-04-01
Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections Grant 6,660,249 - Montgomery December 9, 2	2003-12-09
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections App 20030055034 - Montgomery, Alan Bruce	2003-03-20
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis Grant 6,083,922 - Montgomery July 4, 2	2000-07-04
Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections Grant 5,767,068 - VanDevanter , et al. June 16, 1	1998-06-16

Company Registrations

SEC

0001313936

Montgomery Alan Bruce

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.